PT - JOURNAL ARTICLE AU - Oladejo, Eniola Awolola AU - Sooknunan, Sonill Maharaj TI - Comparative efficacy of interferential therapy, bronchodilators, and body positioning on asthma control and quality of life of patients with bronchial asthma: Study protocol AID - 10.1101/2021.11.29.21267003 DP - 2021 Jan 01 TA - medRxiv PG - 2021.11.29.21267003 4099 - http://medrxiv.org/content/early/2021/12/02/2021.11.29.21267003.short 4100 - http://medrxiv.org/content/early/2021/12/02/2021.11.29.21267003.full AB - Background Interferential therapy (IFT) is the application of two medium frequency currents to the skin to stimulate and activate different systems in the body using specific frequencies and frequency ranges. IFT aims to reduce myalgia in the chest and upper back, reduce muscular fatigue and induce mucus expectoration. This study is designed to compare the efficacy of IFT on asthma control and quality of life of asthma patients pre-and post-administration of bronchodilators and determine the most influential body position in its application.Methods Forty-eight (48) patients aged 18 years and above with bronchial Asthma attending the respiratory clinic at the Lagos State University Teaching Hospital, Ikeja (LASUTH) will be assessed for the study eligibility. The study design will be a double-blinded, randomized control trial with four intervention groups and four parallel placebo control groups. IFT will be administered as an intervention to patients on short and long-acting bronchodilators in an assigned fundamental body position for 20 minutes. Six continuous outcome variables at different points will be utilized as an outcome measure. Baseline Pulmonary Function Test (PFT) will be assessed on entry into the study, Quality of life and asthma control will be evaluated every two (2) weeks of the study. Data obtained will be analyzed using descriptive and inferential statistics of repeated ANOVA; P<0.05.Discussion The study outcome will compare the efficacy of IFT on Bronchial Asthma, identify its effect in different body positions, and compare the relationship between its application and the bronchodilator medication frequently used by the patients.Trial Registration https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10942:PACTR202005807526130Competing Interest StatementThe authors have declared no competing interest.Clinical Trialhttps://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10942Clinical Protocols https://www.pagepressjournals.org/index.php/hls/authorDashboard/submission/10251 Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Biomedical Research Ethics Committee has approved this study of the University of KwaZulu Natal (South Africa) (Ethics Number: BREC/00001883/2020), and by the Human Research Ethics Committee of Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria, West Africa (LREC/06/10/1385).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe corresponding author will make available the datasets for the study upon reasonable request. However, the findings from the study would be made available to participating researchers as required by law. https://drive.google.com/drive/folders/12hZHwBlN0A27BcmAtxp1nGHHr2cVY_Jz?usp=sharing ANOVAAnalysis of VarianceCOPDChronic Obstructive Pulmonary DiseaseFEV1Forced expiratory volume in 1 secondFVCForced Vital CapacityFRCFunctional residual CapacityGLIGlobal Lung InitiativeIFCInterferential CurrentIFTInterferential TherapyLASUTHLagos State University Teaching HospitalLLNLower Level of NormalMANOVAMultiple Analyses of VarianceMSMicrosoftPEFRPeak expiratory flow ratePFTPulmonary Function TestRCTRandomized Control TrialROMRange of MotionSPSSStatistical Package for Social SciencesUKZNUniversity of Kwazulu-Natal